Diagnos Inc. has engaged Investor Brand Network to provide corporate communication and awareness solutions, with IBN receiving a monthly compensation of US$6,400 for one year. IBN will assist Diagnos in enhancing its market awareness profile to maximize shareholder value. IBN is located in Austin, Texas and is acting at arm’s length to the Corporation, with no direct or indirect interest in its securities. The engagement is subject to TSX Venture Exchange acceptance. Diagnos is focused on early detection of critical eye-related health issues using AI technology to improve diagnostic accuracy and patient outcomes globally.

Read more at GlobeNewswire: DIAGNOS Announces the Engagement of IBN